-
Denali Therapeutics (NASDAQ:DNLI) Receives Outperform Rating from William Blair
Source: Buzz FX / 15 Jan 2025 07:30:17 America/Chicago
Denali Therapeutics (NASDAQ:DNLI) Receives Outperform Rating from William Blair Written by MarketBeat January 15, 2025 Share Link copied to clipboard. Denali Therapeutics ( NASDAQ:DNLI - Get Free Report ) 's stock had its "outperform" ratin
Read more...